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ABSTRACTS0963: SURVIVAL RATES FOR PATIENTS WITH ANAPLASTIC THYROID
CARCINOMA RECEIVING DIFFERENT TREATMENT MODALITIES.
Natalie Lowe 1, Beng Yap 2. 1Aintree University Hospital, Liverpool, UK,; 2 The
Christie Hospital, Manchester, UK
Aim: To review which treatments produce greatest survival rates for
patients treated for anaplastic thyroid carcinoma.
Method: The case notes of 20 anaplastic thyroid carcinoma patients
referred to a cancer specialist hospital were retrospectively reviewed.
Results: The median age at diagnosis was 69.5 years (56.3-80.6 years). 19
patients died due to the anaplastic thyroid carcinoma, 8 of whom died
speciﬁcally from asphyxiation. Treatments given at the cancer hospital was
radiotherapy (10 patients), chemotherapy (3 patients), chemotherapy
followed by radiotherapy (3 patients) or no treatment (4 patients). 7
patients had also had surgery in the referring institution prior to referral.
Median survival for all cases was 59 days. Patients who had previous
surgery prior to any other treatment modalities with the oncologists had
a longer median survival time overall compared to those who had not had
previous surgery (142 days compared to 59 days) and produced the one
long term survivor. However, this median survival was not as long as
chemotherapy followed by radiotherapy (with no previous surgery), which
produced a median survival of 220 days.
Conclusion: Chemotherapy followed by radiotherapy produced the
longest survival in this series, even when compared to patients who
received different treatment modalities post surgical resection.
1037: A RETROSPECTIVE STUDY OF CRICOPHARYNGEAL MYOTOMY FOR
NON-SPECIFIC CERVICAL DYSPHAGIA
Pranav Patel, Nilantha De Zoysa, Aaron Trinidade, George
Mochloulis. East and North Herts NHS Trust, Dept of ENT Surgery,
Stevenage, Hertfordshire, UK
Aim: Cricopharyngeal myotomy (CPM) is a well reported management of
dysphagia and tracheo-bronchial aspiration. We aim to analyse outcomes
of CPM in patients with documented cricopharyngeal dysfunction and
those with complex or equivocal diagnoses.
Method: A retrospective analysis was conducted of patients undergoing
CPM between 2001-2010 in a single UK centre. Patients were classiﬁed as
either cricopharyngeal dysfunction (CPD) or non-speciﬁc cervical
dysphagia (NSCD). Study end point was dysphagia recurrence at 12
months. Questionnaires, with validated Visual Analogue Scoring (VAS)
systems were used to quantify dysphagia pre-operative, post-operative, 6
months and 12 months post CPM. Data was analysed with a Wilcoxon
paired t-test (p-value signiﬁcance 0.05).
Results: A total of 28 patients underwent CPM. Pre-operative median
VAS score was 5.5, improving postoperatively to 8.0 (p<0.001). Over
a 12-month period, recurrence was 22% a lower rate in CPD (12.5%) versus
NSCD (60%). Overall complication rate was 15%, most commonly tempo-
rary regurgitation (7.2%), aspiration (1.8%) and perforation (1.8%).
Conclusion: Our results show signiﬁcant improvement in swallowing
solids after CPM on patients with CPD and NSCD. There is low recurrence
and complication rate in patients with radiological evidence for CPD. CPM
can improve swallowing in patients with NSCD, however dysphagia
recurrence remains high.
1039: HRG CODING AND PROFITABILITY FOR COMMON ENT
PROCEDURES: A TWO CYCLE AUDIT
Alistair Mitchell-Innes 2, Damien Gill 1, Richard Harris 3, Hisham
Khalil 1. 1Derriford Hospital, Plymouth, UK; 2City Hospital, Birmingham,
UK; 3 The Royal Melbourne Hospital, Melbourne, Australia
Aim: To evaluate Human Resource Group (HRG) coding accuracy and
proﬁtability for the most common ENT procedures at Derriford
Hospital.
Methods: First cycle (2010): Retrospective analysis of 395 patient
journeys in nine procedures over six months. Intervention: Coding
inaccuracy was discussed with the coding department, and missing
costs identiﬁed.
Second cycle (2011): Using updated codes and costing, the nine procedures
plus thyroidectomy for 528 patients were audited. Proﬁt analysis
comparing consultants and trainees as the main surgeon was performed.
Individual stages of the patient journey were compared for inefﬁciency.Results: Between cycles, miscoding improved from 15% to 8%, whilst
proﬁtable procedures dropped from 8 of 9 to only 3 of 10. Micro-
laryngoscopy was responsible for the majority of miscoding in both
cycles costing the department £24,900 alone in cycle two. Irrespective of
miscoding, however, microlaryngoscopy was also signiﬁcantly less
proﬁtable. Excluding all miscoded procedures the average loss for
trainee cases was £71.69 versus a proﬁt of £49.46 for consultant cases.
There were no isolated processes consistently responsible for delays or
added costs.
Conclusions: Correct coding is vital for trust remuneration. Trainees are
essential, but expensive. In the current ﬁnancial climate, non-proﬁtable
departments risk cuts to staff and procedures.
1066: ULTRASOUND GUIDED INTRA-SUBMANDIBULAR GLAND
INJECTION OF BOTULINUM TOXIN-A (BTX-A) FOR SIALORRHOEA IN
CEREBRAL PALSY PATIENTS
Vanessa Chow, Gulcan Gok, David Howlett. East Sussex Healthcare NHS
Trust, East Sussex, UK
Aim: To investigate the clinical effectiveness of Botulinum Toxin-A(BTX-A)
in the reduction of drooling in patients with cerebral palsy, using ultra-
sound guided intra-submandibular injections.
Method: Four patients with cerebral palsy underwent ultrasound guided
submandibular gland injection of BTX-A under general anaesthetic. The
procedure was performed using high resolution ultrasonography to
identify the superﬁcial lobe of the submandibular gland, vascular struc-
tures and aid in the positioning of 22G needle for administration of 20-25
units of BTX-A. Each procedure was performed by the same radiologist to
avoid operator variation. Drooling severity and frequency was measured at
baseline and reassessed at 4 weeks, using teacher drooling scale and
drooling frequency score.
Results: Three patients reported a subjective improvement in severity and
frequency of drooling, from severe/profuse to mild/moderate. One patient
reported no improvement in severity or frequency of drooling at baseline
and 4 week evaluation. One patient reported side effects, with difﬁcultly
retaining their prosthetic globes within the orbits. This resolved once the
effects of BTX-A had worn off.
Conclusion: Intrasubmadibular gland injection of BTX-A is an effective
treatment to reduce sialorrhoea in patients with cerebral palsy. Ultrasound
guidance enhances the accuracy of injection, however does not eliminate
the risk of side effects.HEPATOPANCREATOBILIARY
0130: A SELECTIVE ANTIBIOTIC PROPHYLAXIS POLICY FOR
LAPAROSCOPIC CHOLECYSTECTOMY IS EFFECTIVE IN MINIMISING
INFECTIVE COMPLICATIONS
Peter Mekhail 2, Fady Yanni 1, Gareth Morris-Stiff 3. 1Yorkshire and Humber
Deanary, Chesterﬁeld, UK; 2Mersey Deanary, Liverpool, UK; 3 Prince Charles
Hospital, Merthyr Tydﬁl, UK
Aim: To assess the effectiveness of a selective antibiotic prophylaxis policy
limited to high risk patients undergoing LC with the development of port-
site infections as the primary endpoint.
Methods: 100 consecutive patients undergoing LC during a 1 year period
were studied prospectively. Data collected included patient demographics,
history of gallstone disease to determine those with risk factors for bac-
tibilia. A single antibiotic dose was administered on induction to high risk
patients. Information relating to all radiologically or microbiologically-
conﬁrmed infections were documented.
Results: 84% were females with mean age 47.7  16.0. 19% of the LCs were
performed as emergencies while 81% were elective. A risk factor for bac-
tibilia was present in 35% of patients. A wound infection was identiﬁed in
4% of cases, 2 of which were Staphylococcus aureus (1 MRSA), 1 was
a coagulase -ve Staphylococcus, and 1 wound cultured a mixed anaerobic
growth. Three of the infections occurred in patients receiving prophylaxis
at intervals of 7, 14 and 19 days respectively. One patient (BMI of 32) in the
no prophylaxis group developed a coagulase -ve staphylococcal infection
at 10 days. No other abdominal infections were identiﬁed.
Conclusions: Restricting antibiotic prophylaxis to high risk patients has no
detrimental effects in terms of increasing the rate of infections in those
with no risk factors.
